304 related articles for article (PubMed ID: 33642826)
21. High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients.
Arab JP; Barrera F; Gallego C; Valderas JP; Uribe S; Tejos C; Serrano C; Serrano C; Huete Á; Liberona J; Labbé P; Quiroga T; Benítez C; Irarrázaval P; Riquelme A; Arrese M
Ann Hepatol; 2016; 15(5):721-8. PubMed ID: 27493111
[TBL] [Abstract][Full Text] [Related]
22. Shear Wave Elastography Reveals a High Prevalence of NAFLD-related Fibrosis even in Type 1 Diabetes.
Meyer G; Dauth N; Grimm M; Herrmann E; Bojunga J; Friedrich-Rust M
Exp Clin Endocrinol Diabetes; 2022 Aug; 130(8):532-538. PubMed ID: 34784620
[TBL] [Abstract][Full Text] [Related]
23. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
[TBL] [Abstract][Full Text] [Related]
24. Liver Stiffness Evaluation by Transient Elastography in Type 2 Diabetes Mellitus Patients with Ultrasound-proven Steatosis.
Sporea I; Mare R; Lupușoru R; Sima A; Sirli R; Popescu A; Timar R
J Gastrointestin Liver Dis; 2016 Jun; 25(2):167-74. PubMed ID: 27308647
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of hepatic steatosis and steatohepatitis in people with new-onset type 2 diabetes: a multidisciplinary approach.
Barana L; Nelva A; Scivetti P; Costanzo M; Fanelli CG
Endocrine; 2024 May; 84(2):412-419. PubMed ID: 38347338
[TBL] [Abstract][Full Text] [Related]
26. Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio-T2DM cohort study.
Leite NC; Villela-Nogueira CA; Ferreira MT; Cardoso CR; Salles GF
Liver Int; 2016 Jul; 36(7):977-85. PubMed ID: 26509555
[TBL] [Abstract][Full Text] [Related]
27. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis.
En Li Cho E; Ang CZ; Quek J; Fu CE; Lim LKE; Heng ZEQ; Tan DJH; Lim WH; Yong JN; Zeng R; Chee D; Nah B; Lesmana CRA; Bwa AH; Win KM; Faulkner C; Aboona MB; Lim MC; Syn N; Kulkarni AV; Suzuki H; Takahashi H; Tamaki N; Wijarnpreecha K; Huang DQ; Muthiah M; Ng CH; Loomba R
Gut; 2023 Nov; 72(11):2138-2148. PubMed ID: 37491159
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study.
Assarrar I; Messaoudi N; Ongoth FEM; Abdellaoui W; Malki A; Rouf S; Abda N; Ismaili Z; Latrech H
Rev Diabet Stud; 2022 Sep; 18(3):140-145. PubMed ID: 36309775
[No Abstract] [Full Text] [Related]
29. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
[TBL] [Abstract][Full Text] [Related]
30. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
Younossi ZM; Golabi P; de Avila L; Paik JM; Srishord M; Fukui N; Qiu Y; Burns L; Afendy A; Nader F
J Hepatol; 2019 Oct; 71(4):793-801. PubMed ID: 31279902
[TBL] [Abstract][Full Text] [Related]
31. Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
Seo DH; Suh YJ; Cho Y; Ahn SH; Seo S; Hong S; Lee YH; Choi YJ; Lee E; Kim SH
Diabetes Metab J; 2022 Jul; 46(4):630-639. PubMed ID: 35081304
[TBL] [Abstract][Full Text] [Related]
32. Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes.
Xie Y; Kong W; Wang X; Wu Z
BMC Endocr Disord; 2022 Aug; 22(1):220. PubMed ID: 36045348
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
[TBL] [Abstract][Full Text] [Related]
34. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
[TBL] [Abstract][Full Text] [Related]
35. Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005-2016.
Ciardullo S; Sala I; Perseghin G
Diabetes Res Clin Pract; 2020 Sep; 167():108358. PubMed ID: 32745698
[TBL] [Abstract][Full Text] [Related]
36. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.
Athyros VG; Polyzos SA; Kountouras J; Katsiki N; Anagnostis P; Doumas M; Mantzoros CS
Curr Vasc Pharmacol; 2020; 18(2):172-181. PubMed ID: 30961499
[TBL] [Abstract][Full Text] [Related]
37. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
[TBL] [Abstract][Full Text] [Related]
38. Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years.
Lee HW; Lee JS; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
J Diabetes Complications; 2021 Jan; 35(1):107747. PubMed ID: 33616043
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
40. Low awareness of non-alcoholic fatty liver disease in patients with type 2 diabetes in Swedish Primary Health Care.
Bergram M; Nasr P; Iredahl F; Kechagias S; Rådholm K; Ekstedt M
Scand J Gastroenterol; 2022 Jan; 57(1):60-69. PubMed ID: 34618619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
